Endocrinology and Metabolism's application to become indexed in the MEDLINE database
was submitted in February 2016. The journal received notice that it had not been selected
in June 23, 2016. Table 1 presents the results of the Journal Review Summary by the
United States National Medical Library Literature Selection Technical Review Committee
(LSTRC). In this editorial, I would like to analyze the summary, to propose a path
toward addressing the areas for improvement, and to speculate on the prospects of
the journal. Other comments from the committee were as follows:
(1) Area(s) for improvement: Editorial board members are listed without credentials.
There are signs of poor editorial work (e.g., a single author review which alternated
between the singular pronouns “I” and “We” throughout the article). Lax ethics practice,
e.g., a case report showed a barely disguised full facial photograph without an ethics
statement (e.g., patient's consent). The journal has a relatively low unsolicited
rate of 70%, with very high acceptance rate of 67%—this acceptance rate could be lowered.
There is a lack of high-quality content (e.g., randomized controlled trials or systematic
reviews). The journal could widen its regional scope.
(2) Overall comments: This is a medical journal that promotes clinical and translational
science in the area of endocrinology and metabolism. It is a regional journal (Korea).
Some of the Korean authorship includes collaborations with Europe or the United States.
Animal, ethical, and Institutional Review Board (IRB) statements are provided in the
Methods section of articles. However, there is some inconsistency in the following
of these ethical guidelines (written consent and IRB statements are lacking in a few
articles). The website is very user-friendly and articles are available in several
different formats.
The committee gave the journal an overall rating of 3 on a Likert scale from 0 to
5, with 5 being the highest rating. The committee also noted that “The LSTRC assessment
of journals is based on several critical elements that serve as a general guide for
recommending a journal title to be indexed in Medline. There is no one element by
itself that tends to disqualify a journal from being recommended. The overall appraisal
of a journal's scientific content, quality, importance, editorial policies, and subject
coverage in Medline determine the LSTRC scoring and recommendation.”
The comments that the LSTRC provided on the journal editing and publishing were meticulous
and showed evidence of their close analysis. Incidentally, it should be noted that
informed consent for the patient's photograph mentioned in the comments was received
during the article submission process; however, mention of the informed consent was
omitted from the article. Also worth noting is that full text of the journal is available
in PubReader, ePub, and PDF formats.
A PROPOSED STRATEGY FOR ACTION ON THE BASIS OF THE LSTRC COMMENTS
First, the journal deserves recognition for the positive comments on the quality of
the journal website. Many of the other comments can be addressed. For example, the
Open Researcher and Contributor ID (ORCID) is one of the standard ID systems used
worldwide for researchers [1]. ORCID of all editorial board members can be announced
publicly. Another way to address the comments is to acquire more meticulous English
proofreading to be provided by a professional English proofreading company. An ethics
editor should also be recruited to take responsibility for the enforcement of research
and publication ethics. The journal also needs to reduce its acceptance rate. To do
so, the number of submissions must increase. Providing better services to attract
more submissions would include a rapid review process; fluent and informative review
comments; prompt decisions on acceptance for publication; ePub ahead of print for
accepted manuscripts; and the continuous removal of the author's article processing
charge. A call for submission of randomized controlled trials and systematic reviews
should be announced to not only the Korean Endocrine Society members but also all
researchers worldwide. To broaden the scope of the journal to an international level,
the journal is already welcoming submissions from investigators in the Asia-Pacific
region and throughout the rest of the world. From 2014 to 2016, the journal published
articles from 17 countries. The editorial board members already represent 19 countries
now. An invitation to potential board members from additional countries would provide
an opportunity to recruit more manuscripts from board members' countries.
To recruit authors from all over the world, one of the most important incentives may
be being listed in international databases. The journal has been searchable in the
EBSCO database since 2012. It has been made accessible throughout the world through
ScienceCentral (http://e-sciencecentral.org) that is free or open access full-text
archives of scientific society journal literature at the Korean Federation of Science
and Technology Societies, as of December 2013. The ScienceCentral database provides
translation into 80 other languages in the world in collaboration with Google Translate.
Although Google Translate is not perfect, the quality of translation becomes better
year by year because it relies on a deep learning technique. For any two closely related
languages, it is possible to understand the contents without difficulty, for example,
between Korean and Japanese. Between English and French, the translation is also understandable.
Endocrinology and Metabolism began being indexed in PubMed Central on January 10,
2014 and is searchable from the first issue of volume 28, 2013. Automatically, this
made it searchable through PubMed. In August 2015, the journal was notified that it
will be indexed in Scopus. It is now searchable in the Scopus database from the 2014
volume 29, number 1 issue. On September 28, 2016, it was first listed in the Directory
of Open Access Journals (DOAJ, http://doaj.org/). To be searchable in DOAJ, it is
recommended that XML metadata be deposited soon. The indexing status in the abovementioned
databases may increase submissions from all over the world. Besides this, the journal
is now under consideration by Clarivate Analytics for inclusion in the Web of Science
Core Collection.
SUGGESTION TO ADOPT AN OPEN DATA POLICY
On October 10, 2016, the International Committee of Medical Journal Editors (ICMJE)
circulated a draft of Data Sharing Plans for Clinical Trials to member journal editors:
“The ICMJE believes there is an ethical obligation to responsibly share data generated
by interventional clinical trials because trial participants have put themselves at
risk [2].” Although the degree of adoption of this data sharing plan may vary according
to the journal's situation, it should be announced that the plan will be adopted by
the journal. Furthermore, the adoption of an open data policy is worth considering.
If raw data are openly available to the researcher, the replication of experiments
and trials can be performed more easily and the data analysis can be more transparent.
In Korea, up to now, only one journal, Journal of Educational Evaluation for Health
Professions, has adopted an open data policy, which began in April 2016 [3]. This
policy provides a means by which the journal can enhance the scientific soundness
of its published studies and encourage higher quality submissions.
MEDLINE JOURNALS IN THE CATEGORY OF ENDOCRINOLOGY
When the United States National Library of Medicine Catalog was searched with the
term “endocrinology (MeSH major topic),” 23 journals were returned as MEDLINE journals.
Among them, 12 are from Europe, 10 from the United States, and one from Japan. Only
one journal title is from Asia, the Endocrine Journal, which is published by the Japan
Endocrine Society. Therefore, it can be concluded that the number of source titles
from Asia on the subject of endocrinology is insufficient. The prevalence of endocrine
diseases including diabetes has increased very fast in Asian countries, including
Korea and China [4]. Information from Asian countries is very important for patient
care and prevention of endocrine diseases throughout the world. Endocrinology and
Metabolism would be a good vehicle for providing that essential information to the
world. There is still a possibility that this journal could be selected for inclusion
in MEDLINE because it can provide unique information on the prevalence and epidemiology
of endocrine diseases in Asian countries.
The review of potential MEDLINE titles is carried out three times a year by the 15
LSTRC members. Each time, up to 140 titles are reviewed. The recommendation rate is
less than 14% [5]. These data showed that it is very difficult to pass the MEDLINE
review. Up to January 2017, 28 journals published in Korea have been listed in MEDLINE
[6]. In the MEDLINE review process, the criteria in Table 1 are an important basis
of evaluation. One another important point is that if any journal can enrich the MEDLINE
database by providing unique medical information, the committee may justify indexing
it [7]. Therefore, recruiting unique articles that cannot be found in other endocrinology
journals in MEDLINE deserves greater focus.
WHY MEDLINE IS WORTH CONTINUING TO PURSUE
Getting listed in MEDLINE enables a journal to have Medical Subject Headings added
to the citation data of the journal in PubMed by professional indexers. Therefore,
a more sensitive and specific search of its articles is possible. Of course, it is
also simply an honor to be recognized as a MEDLINE journal in and of itself. The editorial
board members of Endocrinology and Metabolism do their best to promote the journal,
and the Korean Endocrine Society fully supports the journal publication. Furthermore,
the journal has a unique scope and top-notch editing and publishing quality. Thus
Endocrinology and Metabolism has a great potential to become indexed in MEDLINE.